184 related articles for article (PubMed ID: 14686564)
1. Patient-reported benefits of rizatriptan compared with usual non-triptan therapy for migraine in a primary care setting.
Baos V; Serrano A; Torrecilla M; Bertral C; Caloto MT; Nocea G; Gerth WC;
Int J Clin Pract; 2003 Nov; 57(9):761-8. PubMed ID: 14686564
[TBL] [Abstract][Full Text] [Related]
2. Rizatriptan 10-mg wafer versus usual nontriptan therapy for migraine: analysis of return to function and patient preference.
Pascual J; García-Moncó C; Roig C; Yusta Izquierdo A; López-Gil A;
Headache; 2005 Oct; 45(9):1140-50. PubMed ID: 16178944
[TBL] [Abstract][Full Text] [Related]
3. Migraine treatment with rizatriptan and non-triptan usual care medications: a pharmacy-based study.
Cady R; Martin V; Adelman J; Diamond M; Sajjan S; Hu XH
Headache; 2004 Oct; 44(9):900-7. PubMed ID: 15447699
[TBL] [Abstract][Full Text] [Related]
4. Time to pain freedom and onset of pain relief with rizatriptan 10 mg and prescription usual-care oral medications in the acute treatment of migraine headaches: a multicenter, prospective, open-label, two-attack, crossover study.
Bell CF; Foley KA; Barlas S; Solomon G; Hu XH
Clin Ther; 2006 Jun; 28(6):872-80. PubMed ID: 16860170
[TBL] [Abstract][Full Text] [Related]
5. Effects on productivity and quality of life of rizatriptan for acute migraine: a workplace study.
Láinez MJ; López A; Pascual AM
Headache; 2005; 45(7):883-90. PubMed ID: 15985105
[TBL] [Abstract][Full Text] [Related]
6. Rizatriptan 5 mg for the acute treatment of migraine in adolescents: results from a double-blind, single-attack study and two open-label, multiple-attack studies.
Visser WH; Winner P; Strohmaier K; Klipfel M; Peng Y; McCarroll K; Cady R; Lewis D; Nett R;
Headache; 2004 Oct; 44(9):891-9. PubMed ID: 15447698
[TBL] [Abstract][Full Text] [Related]
7. Long-term efficacy and tolerability of rizatriptan wafers in migraine.
Cady R; Crawford G; Ahrens S; Hairwassers D; Getson A; Visser WH; Lines C;
MedGenMed; 2001 Jun; 3(3):1. PubMed ID: 11549974
[TBL] [Abstract][Full Text] [Related]
8. [Satisfaction and recovery of normal activity with rizatriptan 10 mg. Results from the open, prospective, observational 4M study].
Mateos V; Roig C; López Rodríguez I; López-Gil A
Neurologia; 2002 Dec; 17(10):621-7. PubMed ID: 12487957
[TBL] [Abstract][Full Text] [Related]
9. Early treatment of migraine with rizatriptan: a placebo-controlled study.
Mathew NT; Kailasam J; Meadors L
Headache; 2004; 44(7):669-73. PubMed ID: 15209688
[TBL] [Abstract][Full Text] [Related]
10. Use of a structured migraine diary improves patient and physician communication about migraine disability and treatment outcomes.
Baos V; Ester F; Castellanos A; Nocea G; Caloto MT; Gerth WC;
Int J Clin Pract; 2005 Mar; 59(3):281-6. PubMed ID: 15857323
[TBL] [Abstract][Full Text] [Related]
11. Patient satisfaction with rizatriptan versus other triptans: direct head-to-head comparisons.
Gerth WC; McCarroll KA; Santanello NC; Vandormael K; Zhang Q; Mannix LK
Int J Clin Pract; 2001 Oct; 55(8):552-6. PubMed ID: 11695077
[TBL] [Abstract][Full Text] [Related]
12. Eletriptan in migraine patients reporting unsatisfactory response to rizatriptan.
Goldstein J; Tiseo PT; Albert KS; Li C; Sikes CR
Headache; 2006; 46(7):1142-50. PubMed ID: 16866718
[TBL] [Abstract][Full Text] [Related]
13. Preference for rizatriptan 10-mg wafer vs. eletriptan 40-mg tablet for acute treatment of migraine.
Láinez MJ; Evers S; Kinge E; Allais G; Allen C; Rao NA; Massaad R; Lis K
Cephalalgia; 2006 Mar; 26(3):246-56. PubMed ID: 16472330
[TBL] [Abstract][Full Text] [Related]
14. Clinical-biochemical correlates of migraine attacks in rizatriptan responders and non-responders.
Sarchielli P; Pini LA; Zanchin G; Alberti A; Maggioni F; Rossi C; Floridi A; Calabresi P
Cephalalgia; 2006 Mar; 26(3):257-65. PubMed ID: 16472331
[TBL] [Abstract][Full Text] [Related]
15. Rizatriptan versus rizatriptan plus rofecoxib versus rizatriptan plus tolfenamic acid in the acute treatment of migraine.
Krymchantowski AV; Bigal ME
BMC Neurol; 2004 Jun; 4():10. PubMed ID: 15222892
[TBL] [Abstract][Full Text] [Related]
16. Rizatriptan vs. rizatriptan plus trimebutine for the acute treatment of migraine: a double-blind, randomized, cross-over, placebo-controlled study.
Krymchantowski AV; Filho PF; Bigal ME
Cephalalgia; 2006 Jul; 26(7):871-4. PubMed ID: 16776704
[TBL] [Abstract][Full Text] [Related]
17. Defeating migraine pain with triptans: a race against the development of cutaneous allodynia.
Burstein R; Collins B; Jakubowski M
Ann Neurol; 2004 Jan; 55(1):19-26. PubMed ID: 14705108
[TBL] [Abstract][Full Text] [Related]
18. Impact of migraine and migraine therapy on productivity and quality of life.
Solomon GD; Santanello N
Neurology; 2000; 55(9 Suppl 2):S29-35. PubMed ID: 11089517
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of Rizatriptan 10 mg administered early in a migraine attack.
Cady R; Martin V; Mauskop A; Rodgers A; Hustad CM; Ramsey KE; Skobieranda F
Headache; 2006 Jun; 46(6):914-24. PubMed ID: 16732837
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of rizatriptan tablets during and between migraine attacks.
Cutler NR; Jhee SS; Majumdar AK; McLaughlin D; Brucker MJ; Carides AD; Kramer MS; Matzura-Wolfe D; Reines SA; Goldberg MR
Headache; 1999 Apr; 39(4):264-9. PubMed ID: 15613223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
